Sort
261,768 grants matching “gene therapy”
Creating Magnetically Inducible Synthetic Gene Networks for Cell and Tissue Therapies
$2,238,589Warren Christopher Ruder · University Of Pittsburgh At Pittsburgh · DP2 · FY2018 · GM
MGH/MIT MORRIS UDALL CENTER OF EXCELLENCE IN PD RESEARCH
$2,238,439Anne B Young · Massachusetts General Hospital · P50 · FY2007 · NS
Integrative Pathophysiology of Solid Tumors
$2,237,643Rakesh K. Jain · Massachusetts General Hospital · P01 · FY2016 · CA
Using Genetics For Early Phenotyping & Prevention of Hypertrophic Cardiomyopathy
$2,237,613Carolyn Y Ho · Brigham And Women'S Hospital · P50 · FY2015 · HL
Adoptive Cell Transfer Immunotherapy of Cancer
$2,237,547Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Gene therapy of cancer
$2,237,547Steven Rosenberg · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Gene-engineered adoptive T cell immunotherapy of GBM
$2,237,545Laura A Johnson · University Of Pennsylvania · DP2 · FY2012 · CA
Dana Farber/ Harvard Cancer Center SPORE in Gastrointestinal Cancer
$2,237,511Brian Matthew Wolpin · Dana-Farber Cancer Inst · P50 · FY2020 · CA
Molecular Mechanisms Regulating Calcium Flux In Salivary Glands
$2,237,203Indu S. Ambudkar · National Institute Of Dental & Craniofacial Research · ZIA · FY2015 · DE
Human Trial of Allosteric Modulator Alpha7 Nicotinic Receptors in Schizophrenia
$2,237,158Robert Freedman · University Of Colorado Denver · U01 · FY2011 · MH
Cardiac Gene Transfer of AC & Mechanisms for Effects
$2,236,747H. Kirk Hammond · Veterans Medical Research Fdn/San Diego · P01 · FY2008 · HL
Long-term Follow-up of the Systemic Immunosuppressive Therapy for Eye Diseases Cohort
$2,236,075John H. Kempen · Massachusetts Eye And Ear Infirmary · R01 · FY2025 · EY
Clinical Genomics and Experimental Therapeutics
$2,235,970Falk Lohoff · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2025 · AA
Cancer Center Support Grant
$2,235,000Cornelia M Ulrich · University Of Utah · P30 · FY2019 · CA
A phase I trial of AdKCNH2-G628S gene therapy for post-op atrial fibrillation
$2,234,675J Kevin Donahue · Univ Of Massachusetts Med Sch Worcester · R33 · FY2022 · HL
Frontotemporal Dementias: Genotypes and Phenotypes
$2,234,654Virginia M Lee · University Of Pennsylvania · P01 · FY2019 · AG
NATIONAL INSTITUTE OF HEALTH (NIH), NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES (NCATS), BESPOKE GENE THERAPY CONSORTIUM - COORDINATION CENTER
$2,234,205Black Canyon Consulting Llc · N02 · FY2023 · OD
Cancer Center Support (CORE) Grant
$2,234,001Richard P Woychik · Jackson Laboratory · P30 · FY2007 · CA
Mechanisms and models of C11or95 and C11or95-RELA fusions (RELAFus )
$2,233,776Richard Gilbertson · Fred Hutchinson Cancer Research Center · U54 · FY2019 · CA
Randomized Phase II Trial of Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women with Hormone Receptor Positive Advanced Breast Cancer (FastER)
$2,233,701Tracy E Crane · University Of Miami School Of Medicine · R01 · FY2025 · CA
Revealing the single cell determinants of brain relevant to persistent HIV infection and opioid use disorder
$2,233,422Tariq M Rana · University Of California, San Diego · U01 · FY2024 · DA
RNAi and Epigenetic Control of Higher-Order Chromatin Assembly
$2,233,363Shivinder S Grewal · Basic Sciences · Z01 · FY2007 · CA
SPORE in Genitourinary Cancer
$2,233,299Colin P Dinney · University Of Tx Md Anderson Can Ctr · P50 · FY2009 · CA
SPORE in Genitourinary Cancer
$2,233,298Colin P Dinney · University Of Tx Md Anderson Can Ctr · P50 · FY2010 · CA
SPORE in Breast Cancer
$2,233,067Sara Sukumar · Johns Hopkins University · P50 · FY2008 · CA